About CanBas Co Ltd

About company

CanBas is a biopharmaceutical company that research and develops anti-cancer drugs. The company develops CBP501 which completes phase II clinical trials for the treatment of malignant pleural mesothelioma and non-small cell lung cancers. It also develops CBS9106, a reversible XPO-1 inhibitor for the treatment of solid tumors. CanBas is a Japan-based company that was founded in 2000.